My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 192

    1.

    Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1.

    Ishii Y, Kondo K, Matsumoto T, Tanaka K, Shinkai-Ouchi F, Hagiwara K, Kanda T.

    Virol J. 2007 Oct 26;4:110.PMID: 17961263 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm.

    Kawana Y, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T.

    J Virol. 2001 Mar;75(5):2331-6.PMID: 11160736 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cell surface-binding motifs of L2 that facilitate papillomavirus infection.

    Yang R, Day PM, Yutzy WH 4th, Lin KY, Hung CF, Roden RB.

    J Virol. 2003 Mar;77(6):3531-41.PMID: 12610128 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Arrangement of L2 within the papillomavirus capsid.

    Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, Trus BL.

    J Virol. 2008 Jun;82(11):5190-7. Epub 2008 Mar 26.PMID: 18367526 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Nuclear import strategies of high risk HPV16 L1 major capsid protein.

    Nelson LM, Rose RC, Moroianu J.

    J Biol Chem. 2002 Jun 28;277(26):23958-64. Epub 2002 Apr 23.PMID: 11971900 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Human papillomavirus 16 minor capsid protein L2 helps capsomeres assemble independently of intercapsomeric disulfide bonding.

    Ishii Y, Ozaki S, Tanaka K, Kanda T.

    Virus Genes. 2005 Dec;31(3):321-8.PMID: 16175337 [PubMed - indexed for MEDLINE]Related articles

    9.

    Interaction of L2 with beta-actin directs intracellular transport of papillomavirus and infection.

    Yang R, Yutzy WH 4th, Viscidi RP, Roden RB.

    J Biol Chem. 2003 Apr 4;278(14):12546-53. Epub 2003 Jan 30.PMID: 12560332 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry.

    Hindmarsh PL, Laimins LA.

    Virol J. 2007 Feb 26;4:19.PMID: 17324266 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Interactions between papillomavirus L1 and L2 capsid proteins.

    Finnen RL, Erickson KD, Chen XS, Garcea RL.

    J Virol. 2003 Apr;77(8):4818-26.PMID: 12663788 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Nuclear location of minor capsid protein L2 is required for expression of a reporter plasmid packaged in HPV51 pseudovirions.

    Kondo K, Ishii Y, Mori S, Shimabukuro S, Yoshikawa H, Kanda T.

    Virology. 2009 Nov 25;394(2):259-65. Epub 2009 Sep 19.PMID: 19766281 [PubMed - indexed for MEDLINE]Related articles

    13.

    Role of L2 cysteines in papillomavirus infection and neutralization.

    Gambhira R, Jagu S, Karanam B, Day PM, Roden R.

    Virol J. 2009 Oct 27;6:176.PMID: 19860897 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Binding and neutralization efficiencies of monoclonal antibodies, Fab fragments, and scFv specific for L1 epitopes on the capsid of infectious HPV particles.

    Culp TD, Spatz CM, Reed CA, Christensen ND.

    Virology. 2007 May 10;361(2):435-46. Epub 2007 Jan 12.PMID: 17222883 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Target cell cyclophilins facilitate human papillomavirus type 16 infection.

    Bienkowska-Haba M, Patel HD, Sapp M.

    PLoS Pathog. 2009 Jul;5(7):e1000524. Epub 2009 Jul 24.PMID: 19629175 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly.

    Li M, Beard P, Estes PA, Lyon MK, Garcea RL.

    J Virol. 1998 Mar;72(3):2160-7.PMID: 9499072 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells.

    Aires KA, Cianciarullo AM, Carneiro SM, Villa LL, Boccardo E, Pérez-Martinez G, Perez-Arellano I, Oliveira ML, Ho PL.

    Appl Environ Microbiol. 2006 Jan;72(1):745-52.PMID: 16391114 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation.

    Okun MM, Day PM, Greenstone HL, Booy FP, Lowy DR, Schiller JT, Roden RB.

    J Virol. 2001 May;75(9):4332-42.PMID: 11287582 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Human papillomavirus type 16 and 18 L1 protein peptide binding to VERO and HeLa cells inhibits their VLPs binding.

    Vera-Bravo R, Ocampo M, Urquiza M, García JE, Rodríguez LE, Puentes A, López R, Curtidor H, Suárez JE, Torres E, Guzmán F, Díaz D, Cortes J, Bravo MM, Cómbita AL, Orozco O, Patarroyo ME.

    Int J Cancer. 2003 Nov 10;107(3):416-24.PMID: 14506742 [PubMed - indexed for MEDLINE]Related articles

    20.

    Concatenated multitype L2 fusion proteins as candidate prophylactic pan-human papillomavirus vaccines.

    Jagu S, Karanam B, Gambhira R, Chivukula SV, Chaganti RJ, Lowy DR, Schiller JT, Roden RB.

    J Natl Cancer Inst. 2009 Jun 3;101(11):782-92. Epub 2009 May 26.PMID: 19470949 [PubMed - indexed for MEDLINE]Related articlesFree article

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination
    Write to the Help Desk